Brad Miles founded BMC Communications Group LLC, in 1996 as a public relations agency focused exclusively on the needs of emerging and established health-care companies. Brad has more than 15 years of experience in the health care public relations agency setting, where he developed communications strategies for biotechnology and pharmaceutical companies in both corporate and product practice areas. Prior to founding BMC, Brad was Senior Vice President of Ted Klein & Company (1990 to 1996), a New York-based pharmaceutical public relations agency. At Ted Klein & Company, he directed new product introductions of Bristol-Myers Squibb’s BuSpar and Stadol NS, and worked on corporate strategies around the cancer drug blockbuster, Taxol. Brad also developed product communications for brands Nicorette and Seldane. At BMC he has provided strategic guidance to more than 50 private and publicly traded biotechnology companies, advising management on strategies around product pipeline progress through FDA approvals and launch. He built BMC into a leading, independent public relations firm serving biotechnology companies. Brad began his career in Washington, D.C., as a public affairs specialist at the U.S. Department of Commerce, and then as Director of Public Relations for a leading telecommunications trade group. He lives in lower Manhattan with his wife and son.

Michael Roth is partner at BMC Communications Group LLC, a health care communications consultancy located in the heart of downtown New York City. Prior to joining BMC, Michael served as Executive Director, Communications for Novartis Corporation, where he was responsible for its corporate reputation advertising and public relations campaigns. Prior to Novartis, Michael was Head of GCI’s New York Healthcare Practice (a division of Grey Advertising/WPP), where he was responsible for the strategic oversight of one of the world's largest health care PR practices. His background as both health care communications practitioner and lawyer lead to extensive experience as senior counselor in a wide range of areas including litigation support, issues management, regulatory affairs and pre- and post- approval marketing. Michael is Chair of the 2005 Public Relations Society of America (PRSA) Health Academy. He is also on the Board of Trustees of the Huntington's Disease Society of America (HDSA) and Chair of its Executive Marketing Committee. Michael received his Juris Doctorate (J.D.) from the University of Missouri and was a staff member of Law Review. He was admitted to the New York and New Jersey Bar Associations in August 1993. Michael received his bachelor of arts degree in English Literature and Philosophy of Law at the State University of New York at Buffalo, graduating magna cum laude and was inducted into the Omicron Chapter of Phi Beta Kappa in May 1988. He lives in Irvington, New York with his wife and two children.